126 related articles for article (PubMed ID: 4899416)
1. [Double-blind study using flufenamic acid (F.I. 440) and oxyphenylbutazone in rheumatoid arthritis and ankylosing spine].
Beltrán Gutiérrez J; Fernández del Vallado P; Gijón Baños J
Rev Esp Reum Enferm Osteoartic; 1968 Oct; 12(8):219-21. PubMed ID: 4899416
[No Abstract] [Full Text] [Related]
2. [Pharmacological properties of a series of derivatives of mefenamic and flufenamic acids].
Linari G; Spanò R
Farmaco Sci; 1971 Apr; 26(4):303-11. PubMed ID: 5559990
[No Abstract] [Full Text] [Related]
3. Discussion on clinical trials of the fenamates.
Ann Phys Med; 1966; Suppl():129-34. PubMed ID: 5306340
[No Abstract] [Full Text] [Related]
4. [Contribution to the evaluation of anti-inflammatory agents in vitro].
Mörsdorf K; Cornelissen G
Med Pharmacol Exp Int J Exp Med; 1966; 15(4):399-403. PubMed ID: 6012770
[No Abstract] [Full Text] [Related]
5. [Clinical study of a new anthranilic acid derivative: flufenamic acid].
Colombo B; Chériè Lignière G; Mantellini P
Reumatismo; 1969; 21(3):114-21. PubMed ID: 4929605
[No Abstract] [Full Text] [Related]
6. Flufenamic acid in rheumatoid arthritis.
Drug Ther Bull; 1967 Dec; 5(26):103-4. PubMed ID: 6078914
[No Abstract] [Full Text] [Related]
7. Potentiation by synthetic fibrinolytic agents of vascular activator- and urokinase-induced lysis of human plasma clots as demonstrated by thrombelastography.
Aoki N; von Kaulla KN
Thromb Diath Haemorrh; 1972 Apr; 27(2):246-51. PubMed ID: 5049614
[No Abstract] [Full Text] [Related]
8. [Flufenamic acid in the therapy of rheumatoid arthritis].
Gigante D; Teodori S
Clin Ter; 1968 Jul; 46(1):3-13. PubMed ID: 5703789
[No Abstract] [Full Text] [Related]
9. [Clinical experience with the flufenamic acid--thyocolchicoside combination].
López Prats JL
Rev Esp Reum Enferm Osteoartic; 1970 Jul; 13(7):405-12. PubMed ID: 5501543
[No Abstract] [Full Text] [Related]
10. [Effect of antirheumatic agents on DNA-systems and DNA repair of various cell systems].
Klein G; Wottawa A
Verh Dtsch Ges Rheumatol; 1976; 4():483-8. PubMed ID: 1036643
[No Abstract] [Full Text] [Related]
11. [The new anti-inflammatory acids. Niflumic acid in rheumatology].
Camus JP
Presse Med (1893); 1968 May; 76(22):1071-2. PubMed ID: 5300745
[No Abstract] [Full Text] [Related]
12. [Pharmacological testing of a new anti-inflammatory agent: 1-(m-trifluoromethylphenyl)-N-nitroso anthranilic acid].
Zoni G; Molinari ML; Banfi S
Farmaco Sci; 1971 Jun; 26(6):525-46. PubMed ID: 5561809
[No Abstract] [Full Text] [Related]
13. Flufenamic acid in rheumatoid arthritis. The second six months of treatment.
Simpson MR; Simpson NR; Masheter HC; Hardy SM
Ann Phys Med; 1966; Suppl():110-3. PubMed ID: 6004859
[No Abstract] [Full Text] [Related]
14. [Evaluation of the therapeutic action of flufenamic acid in patients with chronic polyarthritis in a double blind study].
Mathies H; Eichhorn M
Med Monatsschr; 1967 Nov; 21(11):510-6. PubMed ID: 4893773
[No Abstract] [Full Text] [Related]
15. [Flufenamic acid. Double-blind clinical tests in repeated series during 2 and one-half years].
López Prats JL; Valdés M
Rev Esp Reum Enferm Osteoartic; 1968 Oct; 12(8):215-6. PubMed ID: 4899415
[No Abstract] [Full Text] [Related]
16. New drugs. 8. Flufenamic acid in rheumatoid arthritis. Comparison with aspirin and the results of extended treatment.
Simpson MR; Simpson NR; Masheter HC
Ann Phys Med; 1966 May; 8(6):208-13. PubMed ID: 5937788
[No Abstract] [Full Text] [Related]
17. [Mefenamic acid in the therapy of rheumatoid arthritis. Clinical experiments and biohumoral control with the double-blind method. (Preliminary observations)].
D'Ingianna E
Reumatismo; 1967; 19(3):180-2. PubMed ID: 4890710
[No Abstract] [Full Text] [Related]
18. An investigation of possible synergism between flufenamic acid and prednisone.
Fearnley ME
Ann Phys Med; 1966; Suppl():109-10. PubMed ID: 4895002
[No Abstract] [Full Text] [Related]
19. [Effect of metiazinic acid, ketoprofen, oxyphenbutazone, and flufenamic acid on the enzymes of DNA synthesis and repair in the in vitro experiment].
Klein G; Wottawa A; Altmann H; Eberl R
Arzneimittelforschung; 1974 Dec; 24(12):1975-8. PubMed ID: 4480277
[No Abstract] [Full Text] [Related]
20. Double-blind clinical trial of protacine versus oxyphenbutazone in rheumatic disorders.
Loizzi P; Pipitone V; Bignamini AA
Pharmatherapeutica; 1980; 2(5):285-92. PubMed ID: 7001487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
